Concepedia
Statistics
Publications
26
Citations
1.1K
H-Index
18
Active since
2006
Affiliations
Novo Nordisk (United States)(Current)
Novo Nordisk (Denmark)
Thomson Reuters (United States)
University of Utah
Novo Nordisk (United Kingdom)
Mark Aagren is an author at Novo Nordisk (United States) specializing in pharmacoeconomics, diabetes mellitus, and pharmacy.
Publications per year
2006–2022
Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes
Stephen S. Johnston, C Conner, Mark Aagren et al. · Diabetes Obesity and Metabolism · 2012 · 226 citations
Medicine, Insurance, Internal Medicine +15
Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes
Stephen S. Johnston, Christopher S. Conner, Mark Aagren et al. · Diabetes Care · 2011 · 188 citations · Full text
Medicine, Cardiology, Internal Medicine +16
Cost of Self-Monitoring of Blood Glucose in the United States Among Patients on an Insulin Regimen for Diabetes
Jason Yeaw, Won Chan Lee, Mark Aagren et al. · Journal of Managed Care Pharmacy · 2012 · 97 citations · Full text
Medicine, Internal Medicine, Pharmacoeconomics +17
Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries
John Thygesen, Mark Aagren, S. Arnavielle et al. · Current Medical Research and Opinion · 2008 · 62 citations
Medicine, Ophthalmology, Pharmacoeconomics +17
Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe
Onur Başer, Jonathan Bouchard, Tony DeLuzio et al. · Advances in Therapy · 2010 · 56 citations
Pharmacy, Clinical Pharmacy, Pharmacoeconomics +14
1–5 of 26